TABLE 1

Characteristics of Extraosseous and Transosseous Meningiomas

ParameterVariableExtraosseous (n = 15)Transosseous (n = 67)P
Age (y)55 (51–66)49 (47–61)0.073
Male sex6 (40%)13 (19%)0.087
Pathology
 WHO gradeI9 (60%)56 (84%)NA
II6 (40%)9 (13%)
III0 (0%)2 (3%)
 Histologic subtypeTransitional5 (38%)22 (38%)NA
Meningothelial2 (15%)15 (26%)
Microcystic0 (0%)4 (7%)
Fibroblastic0 (0%)1 (2%)
Secretory0 (0%)5 (9%)
Atypical6 (46%)9 (16%)
Anaplastic0 (0%)2 (3%)
Qualitative imaging
 Meningiomatosis9 (60%)26 (39%)0.134
 LocationParasagittal/parafalcine5 (33%)10 (15%)NA
Convexity6 (40%)12 (18%)
Sphenoid wing3 (20%)42 (63%)
Cerebellopontine0 (0%)2 (3%)
Suprasellar/parasellar1 (7%)1 (1%)
 PET/CT for osseous involvementNo signs of13 (87%)0 (0%)NA
Suggestive of0 (0%)1 (1%)
Consistent with2 (13%)66 (99%)
 CE-MRI for osseous involvementNo signs of9 (60%)12 (18%)NA
Suggestive of5 (33%)19 (28%)
Consistent with1 (7%)36 (54%)
 Peritumoral edemaNone8 (53%)33 (49%)0.858
Mild3 (20%)18 (27%)
Extensive4 (27%)16 (24%)
Quantitative imaging
 Meningioma volume in PET/CT (mL)3.3 (1.6–4.7)12.8 (6.8–32.9)<0.001*
 Meningioma volume in CE-MRI (mL)2.5 (1.4–4.7)10.6 (4.6–22.0)0.001*
 Meningioma SUVmax7.6 (4.3–13.9)14.2 (10.0–22.4)0.011*
 Meningioma SUVmean2.7 (1.9–3.0)4.3 (3.1–5.9)0.001*
 Pituitary SUVmax15.8 (12.9–20.0)15.7 (11.6–19.3)0.852
 Pituitary SUVmean3.7 (3.5–4.2)4.0 (3.3–4.7)0.587
  • * Statistically significant.

  • WHO = World Health Organization; NA = not applicable.

  • Data are count followed by percentage for categoric variables and median followed by interquartile range for continuous variables. Proportion analysis was tested using χ2 test. Nonparametric testing for continuous variables was performed using Mann–Whitney U test.